Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Albuterol Sulfate MDI in Mild Asthma
NCT06154304Phase 3Completed
- Sponsor
- Cipla
- Start
- Dec 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salbutamol in asthma, sponsored by Cipla. Started Dec 2023; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06154304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06154304.